Markets Mixed US Trade Deficit Widens In February
Slightly above 715827949 percent of InflaRx NV's investors are aggressively looking to sell. The analysis of the overall investor sentiment regarding InflaRx NV suggests that a very large number of traders are panicking. InflaRx NV's investing sentiment can be driven by a variety of factors including economic data, InflaRx NV's earnings reports, geopolitical events, and overall market trends.
InflaRx |
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13 percent to 33,446.10 while the NASDAQ fell 0.55 percent to 12,059.75. The SP 500, also fell, dropping, 0.20 percent to 4,092.45.
Read at benzinga.com
 |
InflaRx NV Fundamental Analysis
We analyze InflaRx NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InflaRx NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InflaRx NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
InflaRx NV is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
InflaRx NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InflaRx NV stock to make a market-neutral strategy. Peer analysis of InflaRx NV could also be used in its relative valuation, which is a method of valuing InflaRx NV by comparing valuation metrics with similar companies.
Peers
InflaRx NV Related Equities
| ERAS | Erasca | 3.00 | ||||
| PLX | Protalix Biotherapeutics | 1.34 | ||||
| EWTX | Edgewise Therapeutics | 0.08 | ||||
| CCCC | C4 Therapeutics | 0.52 | ||||
| IKNA | Ikena Oncology | 0.62 | ||||
| INZY | Inozyme Pharma | 0.71 | ||||
| KRON | Kronos Bio | 1.00 | ||||
| EYPT | Eyepoint Pharmaceuticals | 1.19 | ||||
| STOK | Stoke Therapeutics | 3.76 | ||||
| KZR | Kezar Life | 3.94 | ||||
| ELDN | Eledon Pharmaceuticals | 4.66 | ||||
| PASG | Passage Bio | 5.71 | ||||
| RVPH | Reviva Pharmaceuticals | 6.50 | ||||
| HOWL | Werewolf Therapeutics | 7.10 | ||||
| ABOS | Acumen Pharmaceuticals | 7.10 | ||||
| GLUE | Monte Rosa | 8.27 | ||||
| FULC | Fulcrum Therapeutics | 8.38 | ||||
| SLS | Sellas Life | 9.52 | ||||
| GBIO | Generation Bio | 12.50 | ||||
| DSGN | Design Therapeutics | 14.19 |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.